283 related articles for article (PubMed ID: 8837781)
1. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
Claret FX; Hibi M; Dhut S; Toda T; Karin M
Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
[TBL] [Abstract][Full Text] [Related]
2. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
4. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
5. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
[TBL] [Abstract][Full Text] [Related]
7. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
8. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus type 12 early region 1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1.
Brockmann D; Feng L; Kröner G; Tries B; Esche H
Virology; 1994 Feb; 198(2):717-23. PubMed ID: 8291251
[TBL] [Abstract][Full Text] [Related]
11. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
12. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway.
Nilsson M; Ford J; Bohm S; Toftgård R
Cell Growth Differ; 1997 Aug; 8(8):913-20. PubMed ID: 9269900
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
15. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
16. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
17. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
19. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
20. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.
Chinenov Y; Kerppola TK
Oncogene; 2001 Apr; 20(19):2438-52. PubMed ID: 11402339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
